Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 134 Lung Neoplasms 50 Adenocarcinoma of Lung 18 Adenocarcinoma, Bronchiolo-Alveolar 10 Brain Neoplasms 9 NSCLC 8 Neoplasms 5 Neoplasm Metastasis 5 Adenocarcinoma 4 Respiratory Tract Diseases 3 Carcinoma 3 Thoracic Neoplasms 2 Mesothelioma, Malignant 2 Head and Neck Neoplasms 2 Tongue Neoplasms 1 Thyroid Neoplasms 1 Thyroid Carcinoma, Anaplastic 1 Thyroid Cancer, Papillary 1 Stage IV EGFR Mutated Non-Small Cell Lung Cancer 1 Squamous Cell Carcinoma of Head and Neck 1 Solitary Fibrous Tumor, Pleural 1 Small Cell Lung Carcinoma 1 Salivary Gland Neoplasms 1 Respiratory Tract Neoplasms 1 Recurrence 1 Previous Treated Metastatic Non-small Cell Lung Cancer 1 Pleural Effusion, Malignant 1 Parathyroid Neoplasms 1 Non-squamous Non-small Cell Lung Cancer 1 Non-small Cell Lung Cancer Metastatic 1

Interventions

Docetaxel 8 pembrolizumab 7 Pemetrexed 5 Carboplatin 5 Erlotinib Hydrochloride 4 toripalimab 3 rociletinib 3 fludarabine 3 Radiosurgery 3 Paclitaxel 3 Oxaliplatin 3 Nivolumab 3 Gemcitabine 3 Etoposide 3 Cyclophosphamide 3 Cisplatin 3 Bevacizumab 3 lorlatinib 2 atezolizumab 2 Vinorelbine 2 Topotecan 2 Radiotherapy 2 Platinum 2 Itraconazole 2 Irinotecan 2 Interleukin-2 2 Cetuximab 2 Albumin-Bound Paclitaxel 2 vinflunine 1 vandetanib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recurrence × Gefitinib × Thoracic × Clear all

NCT00824746 2013-02-26

ReGaiN

Chonnam National University Hospital

Phase 2 Completed

23 enrolled 9 charts

Carcinoma, Non-Small-Cell Lung, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡